IL9 and fibrosarcoma: We also investigated whether IL-9 affects anti-tumor therapeutic effects in vivo in the MCA205 fibrosarcoma model and we found indeed that neutralization of IL-9 with anti-IL-9 antibody abolished the anti-tumor therapeutic effects of E2f8-knockdown Th9 cells (Supplementary Fig. 8c, d).